Terms: = Kidney tumors AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
330 results:
1. First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid tumors.
Yarchoan M; Powderly JD; Bastos BR; Karasic TB; Crysler OV; Munster PN; McKean MA; Emens LA; Saenger YM; Ged Y; Stagg R; Smith S; Whiting CC; Moon A; Prasit P; Jenkins Y; Standifer N; Dubensky TW; Whiting SH; Ulahannan SV
Cancer Res Commun; 2024 Apr; 4(4):1100-1110. PubMed ID: 38551394
[TBL] [Abstract] [Full Text] [Related]
2. Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial.
Beckermann KE; Asnis-Alibozek AG; Atkins MB; Escudier B; Hutson TE; Kasturi V; McDermott DF; Pal SK; Porta C; Rini BI; Verzoni E
Oncologist; 2024 Mar; 29(3):254-262. PubMed ID: 38262444
[TBL] [Abstract] [Full Text] [Related]
3. A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Lin CC; Garralda E; Schöffski P; Hong DS; Siu LL; Martin M; Maur M; Hui R; Soo RA; Chiu J; Zhang T; Ma B; Kyi C; Tan DS; Cassier PA; Sarantopoulos J; Weickhardt A; Carvajal RD; Spratlin J; Esaki T; Rolland F; Akerley W; Deschler-Baier B; Rispoli L; Samant TS; Chowdhury NR; Gusenleitner D; Kwak EL; Askoxylakis V; De Braud F
Oncoimmunology; 2024; 13(1):2290787. PubMed ID: 38170160
[TBL] [Abstract] [Full Text] [Related]
4. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Shitara K; Rha SY; Wyrwicz LS; Oshima T; Karaseva N; Osipov M; Yasui H; Yabusaki H; Afanasyev S; Park YK; Al-Batran SE; Yoshikawa T; Yanez P; Dib Bartolomeo M; Lonardi S; Tabernero J; Van Cutsem E; Janjigian YY; Oh DY; Xu J; Fang X; Shih CS; Bhagia P; Bang YJ;
Lancet Oncol; 2024 Feb; 25(2):212-224. PubMed ID: 38134948
[TBL] [Abstract] [Full Text] [Related]
5. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
Le Blanc J; Projean D; Savignac S; Léveillé S; Ducas MP; Brisebois-Boyer A; Marsot A
Clin Pharmacokinet; 2024 Feb; 63(2):183-196. PubMed ID: 38127240
[TBL] [Abstract] [Full Text] [Related]
6. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
Grande E; Arranz JÁ; De Santis M; Bamias A; Kikuchi E; Del Muro XG; Park SH; De Giorgi U; Alekseev B; Mencinger M; Izumi K; Schutz FA; Puente J; Li JR; O'Donnell PH; Kalebasty AR; Ye D; Mariathasan S; Bene-Tchaleu F; Bernhard S; Lee C; Davis ID; Galsky MD
Lancet Oncol; 2024 Jan; 25(1):29-45. PubMed ID: 38101433
[TBL] [Abstract] [Full Text] [Related]
7. Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
Bauer TM; Santoro A; Lin CC; Garrido-Laguna I; Joerger M; Greil R; Spreafico A; Yau T; Goebeler ME; Hütter-Krönke ML; Perotti A; Juif PE; Lu D; Barys L; Cremasco V; Pelletier M; Evans H; Fabre C; Doi T
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030303
[TBL] [Abstract] [Full Text] [Related]
8. Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study.
Yan XQ; Ye MJ; Zou Q; Chen P; He ZS; Wu B; He DL; He CH; Xue XY; Ji ZG; Chen H; Zhang S; Liu YP; Zhang XD; Fu C; Xu DF; Qiu MX; Lv JJ; Huang J; Ren XB; Cheng Y; Qin WJ; Zhang X; Zhou FJ; Ma LL; Guo JM; Ding DG; Wei SZ; He Y; Guo HQ; Shi BK; Liu L; Liu F; Hu ZQ; Jin XM; Yang L; Zhu SX; Liu JH; Huang YH; Xu T; Liu B; Sun T; Wang ZJ; Jiang HW; Yu DX; Zhou AP; Jiang J; Luan GD; Jin CL; Xu J; Hu JX; Huang YR; Guo J; Zhai W; Sheng XN
Ann Oncol; 2024 Feb; 35(2):190-199. PubMed ID: 37872020
[TBL] [Abstract] [Full Text] [Related]
9. First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Cytryn SL; Moy RH; Cowzer D; Shah RH; Chou JF; Joshi SS; Ku GY; Maron SB; Desai A; Yang J; Sugarman R; Rao D; Goldberg Z; Charalambous C; Lapshina M; Antoine A; Socolow F; Trivedi N; Capanu M; Gerdes H; Schattner MA; Simmons M; Lacouture ME; Paroder V; Tang LH; Shia J; Ilson DH; Solit DB; Berger MF; Janjigian YY
Lancet Oncol; 2023 Oct; 24(10):1073-1082. PubMed ID: 37666264
[TBL] [Abstract] [Full Text] [Related]
10. Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial.
Albiges L; Gurney H; Atduev V; Suarez C; Climent MA; Pook D; Tomczak P; Barthelemy P; Lee JL; Stus V; Ferguson T; Wiechno P; Gokmen E; Lacombe L; Gedye C; Perini RF; Sharma M; Peng X; Lee CH
Lancet Oncol; 2023 Aug; 24(8):881-891. PubMed ID: 37451291
[TBL] [Abstract] [Full Text] [Related]
11. Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy: a case report.
Yang Z; Xu H; Gou S; Wu H; Hu Z
BMC Nephrol; 2023 May; 24(1):145. PubMed ID: 37226096
[TBL] [Abstract] [Full Text] [Related]
12. Comparison between minimally invasive partial nephrectomy and open partial nephrectomy for complex renal tumors: a systematic review and meta-analysis.
Li KP; Chen SY; Wang CY; Yang L
Int J Surg; 2023 Jun; 109(6):1769-1782. PubMed ID: 37094827
[TBL] [Abstract] [Full Text] [Related]
13. Predictors of recurrence of cancer-associated venous thromboembolism after discontinuation of anticoagulant therapy: a multicenter cohort study.
Lapébie FX; Bura-Rivière A; Espitia O; Bongard V; Ciammaichella MM; Martínez JG; Sigüenza P; Giménez JC; Bertoletti L; Monreal M
J Thromb Haemost; 2023 Aug; 21(8):2189-2201. PubMed ID: 37068594
[TBL] [Abstract] [Full Text] [Related]
14. Techniques and outcomes of robot-assisted partial nephrectomy for the treatment of multiple ipsilateral renal masses.
Buffi N; Uleri A; Paciotti M; Lughezzani G; Casale P; Diana P; DE Groote R; Sarchi L; Mottaran A; Bravi C; DE Backer P; Amparore D; Fiori C; Porpiglia F; Mottrie A
Minerva Urol Nephrol; 2023 Apr; 75(2):223-230. PubMed ID: 36847584
[TBL] [Abstract] [Full Text] [Related]
15. A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer.
Shore N; Mellado B; Shah S; Hauke R; Costin D; Adra N; Cullberg M; Teruel CF; Morris T
Clin Genitourin Cancer; 2023 Apr; 21(2):278-285. PubMed ID: 36572571
[TBL] [Abstract] [Full Text] [Related]
16. Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study.
Merseburger AS; Attard G; Åström L; Matveev VB; Bracarda S; Esen A; Feyerabend S; Senkus E; López-Brea Piqueras M; Boysen G; Gourgioti G; Martins K; Chowdhury S
Lancet Oncol; 2022 Nov; 23(11):1398-1408. PubMed ID: 36265504
[TBL] [Abstract] [Full Text] [Related]
17. 3D-CRT, IMRT and VMAT for flank irradiation due to pediatric Wilms tumor: A comparative planning study with XCAT phantoms.
Mazonakis M; Lyraraki E; Tolia M; Damilakis J
Phys Med; 2022 Nov; 103():89-97. PubMed ID: 36257232
[TBL] [Abstract] [Full Text] [Related]
18. Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated kidney Cancer.
Zengin ZB; Pal SK; McDermott DF; Escudier B; Hutson TE; Porta C; Verzoni E; Atkins MB; Kasturi V; Rini B
Clin Genitourin Cancer; 2022 Dec; 20(6):553-557. PubMed ID: 36096984
[TBL] [Abstract] [Full Text] [Related]
19. Improving survival in metastatic renal cell carcinoma (mRCC) patients: do elderly patients benefit from expanded targeted therapeutic options?
Eggers H; Schünemann C; Grünwald V; Rudolph L; Tiemann ML; Reuter C; Anders-Meyn MF; Ganser A; Ivanyi P
World J Urol; 2022 Oct; 40(10):2489-2497. PubMed ID: 35916904
[TBL] [Abstract] [Full Text] [Related]
20. Pattern of recurrence and survival after D2 right colectomy for cancer: is there place for a routine more extended lymphadenectomy?
Palmeri M; Peri A; Pucci V; Furbetta N; Gallo V; Di Franco G; Pagani A; Dauccia C; Farè C; Gianardi D; Guadagni S; Bianchini M; Comandatore A; Masi G; Cremolini C; Borelli B; Pollina LE; Di Candio G; Pietrabissa A; Morelli L
Updates Surg; 2022 Aug; 74(4):1327-1335. PubMed ID: 35778547
[TBL] [Abstract] [Full Text] [Related]
[Next]
